Spironolactone can cause liver damage, but it’s rare. The NIH’s LiverTox database gives spironolactone a likelihood score of D, meaning it’s a “possible rare cause of clinically apparent liver injury.” Only a handful of cases have ever been reported, and those were generally mild and resolved on their own. If you’re taking spironolactone and worried about your liver, the overall safety profile is reassuring.
What the Evidence Actually Shows
Clinically apparent liver injury from spironolactone has only been documented in isolated case reports over the drug’s decades of use. The FDA’s prescribing information for Aldactone (the brand-name version) notes that “a very few cases of mixed cholestatic/hepatocellular toxicity, with one reported fatality, have been reported.” That single fatality across the entire history of the drug gives some perspective on how uncommon serious liver problems are.
The pattern of injury, when it does occur, involves a mix of two types: one where bile flow is disrupted (cholestatic) and another where liver cells are directly damaged (hepatocellular). This mixed pattern is typical of idiosyncratic drug reactions, meaning they’re unpredictable and not clearly tied to dose or duration.
How Spironolactone Is Processed by the Liver
Your liver does the heavy lifting when it comes to breaking down spironolactone. The drug is extensively metabolized into several active compounds that actually carry out its therapeutic effects. One of the main metabolites, canrenone, has shown potential to promote liver cell changes in animal studies. Interestingly, the parent drug itself appears to counteract this effect. Spironolactone produces another metabolite that competes for the same liver enzymes canrenone would use to form potentially harmful byproducts, essentially blocking that pathway.
This built-in protective mechanism helps explain why liver injury is so uncommon despite the drug being heavily processed by the liver.
How It Compares to Other Diuretics
Spironolactone isn’t uniquely risky among diuretics. As a class, diuretics have not been linked to a meaningful increase in liver enzyme elevations and have rarely caused clinically apparent liver injury. The few diuretics implicated in rare cases of liver injury include hydrochlorothiazide, acetazolamide, amiloride, triamterene, and spironolactone. None of these stand out as particularly dangerous to the liver.
Spironolactone Is Actually Used to Treat Liver Disease
Here’s something that surprises many people: spironolactone is one of the first-line treatments for fluid buildup (ascites) caused by cirrhosis, which is advanced liver disease. Cirrhosis triggers an overproduction of aldosterone, a hormone that causes the body to retain sodium and water. Spironolactone blocks aldosterone, making it especially effective in this situation.
The American Association for the Study of Liver Diseases considers aldosterone-blocking drugs like spironolactone more effective than loop diuretics for managing ascites, and recommends them as the diuretic of choice. For patients with a first episode of moderate ascites, spironolactone is typically started alone before adding other diuretics. The fact that hepatologists routinely prescribe this drug to patients with severely compromised livers speaks to its liver safety profile.
That said, the FDA label does advise starting with the lowest dose and increasing slowly in patients with cirrhosis, since these patients process drugs differently and are more sensitive to shifts in electrolytes and fluid balance.
Signs of Liver Problems to Watch For
Drug-induced liver injury from any medication tends to show up in similar ways. The symptoms to be aware of include yellowing of the skin or eyes, unusually dark urine, persistent nausea or loss of appetite, upper right abdominal pain, and unusual fatigue. These symptoms can take weeks to months to appear after starting a medication.
Routine liver function testing is not specifically required for spironolactone the way it is for some other medications (like certain cholesterol drugs or antifungals). Your prescriber may check baseline bloodwork before starting you on spironolactone, but the primary monitoring focus is on potassium levels and kidney function, not liver enzymes. The FDA label emphasizes monitoring potassium within one week of starting the drug and regularly after that, along with periodic checks of electrolytes, kidney function, and blood sugar.
If you develop any symptoms suggestive of liver problems while taking spironolactone, blood tests measuring liver enzymes and bilirubin can quickly clarify whether the drug is affecting your liver. In the rare cases that have been reported, stopping the medication led to recovery.